Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial Hypertension

  • Population PK/PD Modeling of Selexipag in PAH Patients
  • A Krause, M Machacek, D Lott, N Hurst, S Bruderer, J Dingemanse
  • CPT Pharmacometrics & Systems Pharmacology, May 2017, Wiley
  • DOI: 10.1002/psp4.12202

The authors haven't yet claimed this publication.

Read Publication


In partnership with:

Link to Wiley showcase